RELMADA THERAPEUTICS, INC. (RLMD) Net Income (Loss) Attributable to Parent USD 2011 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Relmada Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2011 to 2024.
  • Relmada Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$21.8 M, a 17.1% increase year-over-year.
  • Relmada Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$94.3 M, a 34.3% increase year-over-year.
  • Relmada Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$98.8 M, a 37.1% increase from 2022.
  • Relmada Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$157 M, a 24.9% decline from 2021.
  • Relmada Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$126 M, a 112% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$94.3 M -$21.8 M +$4.49 M +17.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$98.8 M -$25.2 M +$12.8 M +33.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 -$112 M -$22 M +$17.4 M +44.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$129 M -$25.3 M +$14.6 M +36.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-08
Q1 2023 -$144 M -$26.3 M +$13.4 M +33.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$157 M -$37.9 M -$3.57 M -10.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 -$153 M -$39.4 M +$3.19 M +7.48% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$157 M -$39.9 M -$13.4 M -50.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-08
Q1 2022 -$143 M -$39.7 M -$17.5 M -78.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-08
Q4 2021 -$126 M -$34.4 M -$13.6 M -65.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$112 M -$42.6 M -$25.7 M -152% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$86.4 M -$26.6 M -$15.4 M -139% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$71 M -$22.2 M -$11.5 M -108% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$59.5 M -$20.8 M -$16.2 M -359% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 -$43.2 M -$16.9 M -$13.2 M -361% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$30 M -$11.1 M -$7 M -170% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$23 M -$10.7 M -$7.99 M -297% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$15 M -$4.53 M +$2.6 M +36.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-24
Q3 2019 -$17.6 M -$3.67 M -$289 K -8.56% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$17.3 M -$4.12 M -$773 K -23.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$16.5 M -$2.69 M +$516 K +16.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-08-12
Q4 2018 -$17.1 M -$7.13 M -$5.7 M -399% Oct 1, 2018 Dec 31, 2018 10-Q 2019-05-15
Q3 2018 -$11.4 M -$3.38 M -$2.4 M -244% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$8.96 M -$3.35 M -$1.72 M -105% Apr 1, 2018 Jun 30, 2018 10-KT 2020-03-26
Q1 2018 -$7.24 M -$3.2 M -$1.22 M -61.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$6.02 M -$1.43 M -$397 K -38.5% Oct 1, 2017 Dec 31, 2017 10-Q 2019-05-15
Q3 2017 -$5.63 M -$982 K +$659 K +40.2% Jul 1, 2017 Sep 30, 2017 10-Q 2019-05-15
Q2 2017 -$6.29 M -$1.63 M +$1.68 M +50.8% Apr 1, 2017 Jun 30, 2017 10-K 2018-09-28
Q1 2017 -$7.97 M -$1.98 M -$122 K -6.55% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$7.85 M -$1.03 M +$1.43 M +58.1% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-12
Q3 2016 -$9.28 M -$1.64 M -$6.3 M -135% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$2.97 M -$3.32 M -$9.36 M -155% Apr 1, 2016 Jun 30, 2016 10-K 2017-09-28
Q1 2016 $6.39 M -$1.86 M +$603 K +24.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $5.78 M -$2.46 M -$7.92 M -145% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-10
Q3 2015 $13.7 M $4.66 M +$34.5 M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$20.8 M $6.04 M Apr 1, 2015 Jun 30, 2015 10-K 2016-09-09
Q1 2015 -$2.46 M -$8.96 M -138% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $5.46 M +$10.6 M Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-05
Q3 2014 -$29.8 M -$28.3 M -1806% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q1 2014 $6.49 M +$7.12 M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$5.17 M -$5.16 M -57182% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-13
Q3 2013 -$1.57 M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q1 2013 -$630 K Jan 1, 2013 Mar 31, 2013 8-K 2014-05-27
Q4 2012 -$9.02 K* Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-13
Q3 2011 -$90* May 23, 2011 Aug 31, 2011 10-K 2013-12-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.